ARTICLE | Clinical News
Ditropan XL oxybutynin chloride: Marketed
July 9, 2001 7:00 AM UTC
Results from a U.S. post-marketing study of Ditropan XL in 14 patients with spinal cord injury and detrusor hyperreflexia (overactive bladder) showed that patients given 30 mg Ditropan XL daily had an...